Top Biotechnology & Medical Research stocks in Australia
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
TLXTelix Pharmaceuticals | AU$5.96bn | 102.01 | n/a |
CU6Clarity Pharmaceuticals | AU$2.33bn | n/a | n/a |
MSBMesoblast | AU$1.05bn | n/a | n/a |
OPTOpthea | AU$698.54m | n/a | n/a |
PYCPYC Therapeutics | AU$637.44m | n/a | n/a |
IMMImmutep | AU$520.47m | n/a | n/a |
IMUImugene | AU$366.02m | n/a | n/a |
RACRace Oncology | AU$289.52m | n/a | n/a |
DXBDimerix | AU$222.83m | n/a | n/a |
LTPLtr Pharma | AU$210.52m | n/a | n/a |
CGSCogstate | AU$162.24m | 20.23 | n/a |
ALAArovella Therapeutics | AU$152.33m | n/a | n/a |
AGNArgenica Therapeutics | AU$101.43m | n/a | n/a |
ACWActinogen Medical | AU$95.21m | n/a | n/a |
PARParadigm Biopharmaceuticals | AU$87.59m | n/a | n/a |
PERPercheron Therapeutics | AU$87.45m | n/a | n/a |
PIQProteomics International Laboratories | AU$78.54m | n/a | n/a |
NTINeurotech International | AU$71.22m | n/a | n/a |
ADOAnteotech | AU$54.30m | n/a | n/a |
IIQInoviq | AU$52.76m | n/a | n/a |